Rhonda Cooper-DeHoff | Genetics and pharmacogenetics | Best Researcher Award

Posted on by ScienceFather

Dr. Rhonda Cooper-DeHoff | Genetics and Pharmacogenetics | Best Researcher Award

Director and Clinical Chair at Fitzpatrick Referrals Ltd, United Kingdom

Professor Noel Fitzpatrick is a distinguished veterinary orthopaedic surgeon with extensive expertise in small animal orthopaedics and sports medicine. Holding numerous prestigious qualifications, including Fellowships and Honorary Doctorates, he has made significant contributions through his roles as Emeritus Professor at the University of Surrey and founder of the Humanimal Trust. With a prolific publication record in veterinary surgery and orthopaedics, his research spans innovative treatments such as stem cell therapy and custom implants for complex conditions. His work in vector control, waste management, and water quality, though less prominent, reflects a commitment to broader environmental health. Fitzpatrick’s collaborative efforts are evident in his leadership of multiple institutions and involvement in interdisciplinary research. Recognized globally for his pioneering approaches and clinical advancements, he has been honored with numerous awards and accolades, solidifying his reputation as a leading figure in veterinary medicine.

Education

Dr. Rhonda M. Cooper-DeHoff has an impressive educational background, laying a strong foundation for her illustrious career in pharmacotherapy and translational research. She began her academic journey at the University of California, San Diego, where she earned a Bachelor of Arts in General Biology from Revelle College in 1982. She then pursued her Doctor of Pharmacy degree at the University of California, San Francisco, completing it in 1986. Dr. Cooper-DeHoff further advanced her expertise by obtaining a Master of Science in Medical Science with a concentration in Clinical Investigation from the University of Florida in 2007. This advanced training, coupled with her extensive post-graduate experience, including a fellowship in the Advanced Postgraduate Program in Clinical Investigation at the University of Florida College of Medicine and a fellowship from the American Heart Association, has equipped her with the knowledge and skills essential for her research and academic contributions in cardiovascular medicine and pharmacogenomics.

Professional Experience

Dr. Rhonda M. Cooper-DeHoff is a distinguished Associate Professor with Tenure in the Department of Pharmacotherapy and Translational Research at the University of Florida’s College of Pharmacy. Her professional journey includes a joint faculty appointment in the Division of Cardiovascular Medicine within the College of Medicine. Dr. Cooper-DeHoff’s career highlights include serving as Associate Director of the Center for Pharmacogenetics, Director of the Graduate Program in Precision Medicine, and roles such as Research Associate Professor and Research Assistant Professor at UF. Her earlier positions involved directing the INVEST Pharmacy Coordinating Center and managing the Clinical Trials Program. Dr. Cooper-DeHoff has contributed significantly to clinical research and education, particularly in cardiovascular and pharmacogenomics fields. Her leadership in various research projects, such as those funded by NIH and PCORI, showcases her expertise in precision medicine, hypertension, and metabolic research.

Research Interests

Dr. Rhonda M. Cooper-DeHoff’s research interests are centered on cardiovascular pharmacotherapy, precision medicine, and the optimization of hypertension management. She focuses on the pharmacogenomic evaluation of antihypertensive responses, aiming to personalize treatment strategies based on genetic profiles. Her work extensively involves clinical trials and comparative effectiveness research, investigating blood pressure control strategies and metabolic impacts of antihypertensive drugs. Dr. Cooper-DeHoff is also engaged in research related to the implementation of genomic medicine in clinical settings, striving to integrate biomarkers and lifestyle factors into personalized care. Her projects address health disparities and rural health challenges, reflecting her commitment to improving cardiovascular health outcomes through innovative and evidence-based approaches. Through her research, Dr. Cooper-DeHoff contributes to advancing precision medicine and enhancing patient care in cardiovascular medicine.

Research Skills

Dr. Rhonda M. Cooper-DeHoff possesses exceptional research skills that span various aspects of clinical and translational science. Her expertise in pharmacogenomics, particularly in the context of antihypertensive drug responses, highlights her adeptness at integrating genetic and clinical data to personalize treatment strategies. Dr. Cooper-DeHoff’s proficiency in managing large-scale, multi-center research projects is evidenced by her role in the NIH-funded PEAR study and her leadership in the PCORI PaCR initiative. Her ability to design and execute clinical trials, coupled with her experience in genomic medicine, underscores her capability to drive impactful research in cardiovascular medicine. Additionally, her involvement in projects such as the UF Moonshot Initiative and the Health Equity Research Institute demonstrates her commitment to addressing health disparities and optimizing clinical care. Dr. Cooper-DeHoff’s extensive publication record and her role in numerous research committees further reflect her deep engagement with advancing medical science.

Awards and Recognition

Dr. Cooper-DeHoff has received numerous awards and honors that recognize her contributions to research, mentorship, and clinical practice. Notable accolades include the UF College of Pharmacy Faculty Mentor of the Year, UF Research Foundation Professor Award, and the Russell R. Miller Award from the American College of Clinical Pharmacy. These awards reflect her excellence and leadership in the field.

Conclusion

Dr. Rhonda M. Cooper-DeHoff’s extensive research contributions, impactful collaborations, applied research achievements, and numerous recognitions make her a highly suitable candidate for the Research for Best Researcher Award. Her work in cardiovascular pharmacotherapy and translational research has significantly advanced the field and improved patient care, demonstrating her outstanding qualifications for this prestigious award.

Publications Top Notes

  1. Implementation of a pharmacogenetic panel-based test for pharmacotherapy-based supportive care in an adult oncology clinic
    • Authors: Cicali, E.J., Eddy, E., Gong, Y., George, T.J., Cooper-DeHoff, R.M.
    • Journal: Clinical and Translational Science
    • Volume: 17(7)
    • Article: e13890
    • Year: 2024
  2. Integrated metabolomics analysis reveals mechanistic insights into variability in blood pressure response to thiazide diuretics and beta blockers
    • Authors: Mehanna, M., McDonough, C.W., Smith, S.M., Johnson, J.A., Cooper-DeHoff, R.M.
    • Journal: Clinical and Translational Science
    • Volume: 17(5)
    • Article: e13816
    • Year: 2024
  3. Circulating microRNA Biomarkers of Thiazide Response in Hypertension
    • Authors: Chekka, L.M.S., Tantawy, M., Langaee, T., Cooper-Dehoff, R.M., Johnson, J.A.
    • Journal: Journal of the American Heart Association
    • Volume: 13(4)
    • Article: e032433
    • Year: 2024
    • Citations: 2
  4. Initial Antihypertensive Prescribing in Relation to Blood Pressure among Florida Medicaid and Medicare Recipients in the OneFlorida+ Research Consortium
    • Authors: Smith, K.M., Keshwani, S., Walsh, M.G., Cooper-Dehoff, R.M., Smith, S.M.
    • Journal: Hypertension
    • Volume: 81(2)
    • Pages: E7-E9
    • Year: 2024
  5. Characteristics and Predictors of Apparent Treatment-Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data
    • Authors: Jafari, E., Cooper-DeHoff, R.M., Effron, M.B., Hogan, W.R., McDonough, C.W.
    • Journal: American Journal of Hypertension
    • Volume: 37(1)
    • Pages: 60-68
    • Year: 2024
    • Citations: 3
  6. In Reply: Probability of Reduced Follow-up Health Care Visits for Controlled Hypertensive Patients
    • Authors: Chamberlain, A.M., Cooper-DeHoff, R.M., Pletcher, M.J.
    • Journal: Mayo Clinic Proceedings
    • Volume: 98(6)
    • Pages: 949
    • Year: 2023
  7. Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale
    • Authors: Joseph, J., Pajewski, N.M., Dolor, R.J., Shivaswamy, V., Ramalingam, R.
    • Journal: Journal of the American Geriatrics Society
    • Volume: 71(6)
    • Pages: 1701-1713
    • Year: 2023
    • Citations: 17
  8. New Drugs Approved in 2022
    • Authors: Ebied, A.M., Elmariah, H., Cooper-DeHoff, R.M.
    • Journal: American Journal of Medicine
    • Volume: 136(6)
    • Pages: 545-550
    • Year: 2023
    • Citations: 1
  9. Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy
    • Authors: Deremer, D.L., Nguyen, N.K., Guha, A., Fradley, M.G., Gong, Y.
    • Journal: Journal of the American Heart Association
    • Volume: 12(10)
    • Article: e027981
    • Year: 2023
    • Citations: 5
  10. Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory
    • Authors: Chamberlain, A.M., Cooper-DeHoff, R.M., Fontil, V., Knowlton, K.U., Pletcher, M.J.
    • Journal: Mayo Clinic Proceedings
    • Volume: 98(5)
    • Pages: 662-675
    • Year: 2023
    • Citations: 7

 

Anam | Genetics and Molecular Biology | Best Scholar Award

Posted on by ScienceFather

Mrs. Anam | Genetics and Molecular Biology | Best Scholar Award

P.hD Biochemistry research scholar  of University of lucknow,lucknow and ICAR-Indian institute of sugarcane research,lucknow, India .

Mrs. Anam is a dedicated researcher with expertise in biotechnology and biochemistry. She holds a Master’s degree in Biotechnology and Chemistry and is currently pursuing a Ph.D. in Biochemistry at the University of Lucknow, India. Mrs. Anam’s research interests encompass molecular biology, biochemical pathways, and biotechnological applications, with a focus on advancing scientific knowledge in these areas. She has valuable professional experience as a Young Professional-1 in the Plant Physiology and Biochemistry Division at ICAR-Indian Institute of Sugarcane Research, where she contributes to cutting-edge research projects. Mrs. Anam’s skills include experimental design, molecular biology techniques, biochemical assays, and data analysis. She is passionate about scientific inquiry, evidenced by her participation in research training programs and academic pursuits. Mrs. Anam’s dedication to research and her multidisciplinary skill set position her as a promising researcher in the field of biotechnology and biochemistry.

Professional Profiles:

Education

Mrs. Anam has attained notable educational qualifications in biotechnology and chemistry, underscoring her commitment to academic excellence and expertise in scientific disciplines. She completed a Master of Science (M.Sc) in Biotechnology, focusing on advanced molecular biology, genetics, and biotechnological applications. This postgraduate degree equips her with specialized knowledge essential for research and development in the biotechnology sector. Additionally, Mrs. Anam holds Bachelor of Science (B.Sc) degrees in Biotechnology and Chemistry, providing a strong foundation in biological sciences and chemical principles. This interdisciplinary educational background enhances her understanding of biochemical processes and their practical applications. Mrs. Anam’s academic achievements reflect her dedication to acquiring comprehensive skills and knowledge necessary for success in biotechnology, research, and laboratory work.

Professional Experience

Mrs. Anam possesses a wealth of professional experience in the dynamic field of biotechnology and biochemistry. Currently pursuing a Ph.D. in Biochemistry at the University of Lucknow, she is actively engaged in advanced research focusing on biochemical processes and their applications in biological systems. As a Young Professional-1 in the Plant Physiology and Biochemistry Division at ICAR-Indian Institute of Sugarcane Research, Lucknow, Mrs. Anam contributes to cutting-edge research projects in plant physiology, biochemistry, and agricultural biotechnology. Her role involves hands-on experimentation and analysis, further enhancing her expertise in applied biotechnological research. Previously, she was selected as a BCIL Trainee through the Biotechnology Industry Training Programme (BITP) by the Department of Biotechnology (DBT), Government of India, and completed a specialized industrial training program at AquaBiochip Genomics India Pvt. Ltd., Biotech Park, Lucknow. These experiences underscore Mrs. Anam’s proficiency in scientific research, laboratory techniques, and industry-relevant applications within the biotechnology field. Her diverse professional journey reflects a strong commitment to advancing knowledge and innovation in biotechnology and biochemistry.

Research Interest

Mrs. Anam’s research interests are diverse and encompass key areas of biotechnology and biochemistry. She is particularly focused on molecular biology, investigating gene expression and cellular processes. Additionally, Mrs. Anam is interested in exploring biochemical pathways and their impact on metabolism and cellular regulation. She is keen on biotechnological applications, aiming to develop innovative solutions for agriculture, healthcare, and environmental sustainability. Her passion extends to immunology and infectious diseases, with a focus on host-pathogen interactions and immune system modulation. In her current role in plant physiology research, Mrs. Anam seeks to understand plant biochemistry to enhance crop productivity and resilience. Through her multidisciplinary approach, she aims to contribute to scientific advancements that address critical societal and environmental challenges.

Award and Honors

Mrs. Anam has been recognized for her academic achievements and dedication to scientific inquiry in biotechnology and biochemistry. Her selection as a BCIL Trainee through the Biotechnology Industry Training Programme (BITP) by the Department of Biotechnology (DBT), Government of India, signifies her academic excellence and potential in biotechnological applications. As a Ph.D. researcher in Biochemistry at the University of Lucknow, Mrs. Anam demonstrates a strong commitment to advanced research and scholarly pursuits. While specific awards and honors may vary, these achievements highlight her academic merit and contributions to the field. Mrs. Anam’s pursuit of excellence in biotechnology and biochemistry positions her as a promising researcher with the potential for further recognition and impactful contributions to the scientific community.

Research Skills

Mrs. Anam possesses a diverse and comprehensive skill set in research methodologies essential for biotechnology and biochemistry. She excels in experimental design, molecular biology techniques (DNA isolation, PCR), biochemical assays (enzyme kinetics, protein analysis), and cell culture. Mrs. Anam is adept at data analysis using statistical tools and bioinformatics software to derive meaningful insights from experimental data. She demonstrates strong scientific writing skills for manuscript preparation and grant proposals, supported by her ability to conduct thorough literature reviews. Proficient in operating laboratory instrumentation and managing research projects, Mrs. Anam exhibits a well-rounded approach to scientific inquiry. Her expertise equips her to contribute significantly to advancing knowledge and innovation in biotechnology, biochemistry, and related fields. Mrs. Anam’s research skills underscore her potential for impactful contributions to scientific research and development endeavors.